percentage of americans on glp 1 The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs 1 in 8 Americans is

Somatostatin analogues are able to slow the rate of gastric emptying, slow small bowel transit, inhibit the release of gastrointestinal hormones, inhibit insulin secretion and inhibit postprandial vasodilation

Participants received tirzepatide (Mounjaro/Zepbound) at escalating doses up to 15 mg weekly for 52 weeks

As a result, clinicians must rely on clinical judgment and individual patient response

Dehydration can make GLP-1 side effects like nausea and constipation worse (this happened to me), and it can really zap your energy, too

Quiz Q1

Includes MB Core (60 capsules) and MB Enhance (30day supply) plus lifestyle resources